Jenny Shliozberg

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b4de2cd0-35dc-11ed-82c6-41b469a7b495.jpg

First Name

Jenny

Last Name

Shliozberg

NPI

1174603971

Faculty ID

1191

CMO Specialties

Clinical Terms

Employment Status

part-time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

EMR ID

3597

Biography

<p>Jenny Shliozberg, MD, is an attending physician at the Children&rsquo;s Hospital at Montefiore Einstein and Associate Professor, Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is in food allergy, hereditary angioedema (HAE), asthma, rhinitis, oral allergy syndrome and chronic urticaria. She frequently conducts food and drug challenges and has cared for HIV-positive and immunodeficient patients for the last 35 years.
</p><p>After earning her Doctor of Medicine at First Pavlov Medical University in St. Petersburg, Russia, Dr. Shliozberg continued with her postgraduate training at the same institution, completing her internship in obstetrics and gynecology followed by an ambulatory obstetrics and gynecology clinic. She later came to the United States, continuing her postgraduate training in 1984, completing a pediatric residency at Beth Israel Medical Center in 1987 and an allergy and immunology fellowship at Montefiore and Einstein in 1989.
</p><p>Dr. Shliozberg&rsquo;s research focus includes food allergy, HAE, chronic sporadic urticaria, study in pediatric asthma, HIV and severe combined immunodeficiency and eosinophilic esophagitis. She is principal investigator on the use of Dupixent for pediatric patients, and has a study on AIR Supra use in children. Dr. Shilozberg has shared her work through peer-reviewed journals, book chapters, abstracts, posters and case reports and she has presented internationally and nationally. She has trained more than 70 fellows, many residents and medical students throughout her career.
</p><p>Dr. Shliozberg is board certified by the American Board of Allergy and Immunology. She is a Fellow of the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Dr. Shliozberg is a member of the American Association of Certified Allergists, the New York Allergy Society, and the Clinical Immunology Society.

</p>

Is Open Scheduling

On

Zocdoc Link

Chirag D. Shah

https://assets.montefioreeinstein.org/profiles/images/physphoto/Shah_Chirag_MD_420x504.jpg

First Name

Chirag

Last Name

Shah

NPI

1164629770

Faculty ID

15234

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

5732

Visit Type ID

2542

Is Open Scheduling

On

Theresa M. Serra

https://assets.montefioreeinstein.org/profiles/images/Serra_Theresa_MD_2x.jpg

First Name

Theresa

Last Name

Serra

NPI

1609164078

Faculty ID

14280

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Pediatric Medicine

Elsevier Profile

EMR ID

55674

Biography

<p class="MsoNormal">Theresa Serra, MD, joined the CHAM hospitalist division in 2014 after working as a pediatric hospitalist at New York Presbyterian/Lower Manhattan Hospital. Her interests include clinical research and medical education. She has conducted an IRB approved retrospective chart review examining readmission rates in pediatric patients diagnosed with osteomyelitis. Dr. Serra is currently developing a medical Spanish curriculum for faculty members in order to improve communication between patients, families and providers. Along with Courtney McNamara, MD, Dr. Serra is a co-leader of a multidisciplinary committee dedicated to standardizing and improving quality of care for patients hospitalized with the diagnosis of failure to thrive. Dr. Serra is also working on an initiative to identify vaccine delinquency in the inpatient setting through the use of SMART reports.</p> <p class="MsoNormal">Dr. Serra is also collaborating with Lindsey Douglas, MD, MSCR, in an IRB approved quality improvement (QI) project to improve transition-of-care communication between hospitalists and primary care providers and to facilitate the establishment of medical homes. Dr. Serra is also a member of a subcommittee that leads monthly journal clubs/case conferences for pediatric hospitalists.</p>

Is Open Scheduling

Off

Adarsha Selvachandran

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/b851f490-5fb9-11ec-9773-d197dc92a0d8.jpg

First Name

Adarsha

Last Name

Selvachandran

NPI

1134578248

Faculty ID

16723

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

87590

Is Open Scheduling

Off

Amrita K. Seehra

https://assets.montefioreeinstein.org/profiles/images/default-profile-blue.svg

First Name

Amrita

Last Name

Seehra

NPI

1538548060

Faculty ID

17827

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

29409

Is Open Scheduling

Off

Robin L. Scott

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/4e97a850-c3de-11eb-9ea2-7374238588d1.jpg

First Name

Robin

Last Name

Scott

NPI

1841376795

Faculty ID

5376

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Elsevier Profile

EMR ID

4128

Is Open Scheduling

Off

Scott J. Schafler

https://assets.montefioreeinstein.org/profiles/images/Scott-Schafler.jpg

First Name

Scott

Last Name

Schafler

NPI

1417219585

Faculty ID

16440

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

55639

Is Open Scheduling

Off

Ali Sadoughi

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0896c190-56c0-11ec-a12b-63debfbf42ce.jpg

First Name

Ali

Last Name

Sadoughi

NPI

1699933879

Faculty ID

14807

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Male

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Dr. Ali Sadoughi is Director of Interventional Pulmonology and Bronchoscopy. His clinical expertise is in interventional pulmonology and thoracic oncology, an evolving sub-specialty of pulmonary and critical care medicine. This field focuses on patients with benign and malignant chest diseases.</p>
<p>Dr. Sadoughi performs advanced diagnostic and therapeutic procedures for patients with lung nodules/masses, intra-thoracic lymphadenopathy, pleural diseases, and severe asthma. These include:</p>
<ul>
<li>Sampling of pulmonary lesions; both peripherally and centrally located in the lung; using endobronchial ultrasound (EBUS, both radial and linear array probes) and navigational bronchoscopy</li>
<li>Therapeutic rigid and flexible bronchoscopy on patients with major airway disorders, including tumor de-bulking, airway dilatation and stent placement</li>
<li>Diagnostic and therapeutic procedures on patients with pleural disease and effusion</li>
<li>Therapeutic interventions such as pleurodesis, tunneled pleural catheter and chest tube placement</li>
<li>Bronchial thermoplasty for severe asthma&nbsp;</li>
<li>Endobronchial valve placement for persistent air leak from the lung</li>
</ul>
<p>His other&nbsp;experience is in ultrasonography and echocardiography and their applications in pulmonary and critical care medicine.</p>
<p>Dr. Sadoughi's research interests are in evolution and application of sophisticated and modern technologies for early and minimally invasive diagnosis and treatment of different pulmonary diseases, from lung cancers, to airway disorders, pulmonary hypertension, interstitial lung disease, respiratory failure, and pleural diseases. The outcome of his research studies in pulmonary hypertension and interventional pulmonology has been published in high-ranking medical journals and presented in different national conferences.</p>
<h3>Clinical Specialties</h3>
<ul>
<li>Pulmonary Medicine
<ul>
<li>Interventional Pulmonology</li>
<li>Lung Cancer</li>
</ul>
</li>
<li>Critical Care</li>
</ul>
<h3>Board Certification</h3>
<ul>
<li>Pulmonary Disease</li>
<li>Critical Care Medicine</li>
<li>Internal Medicine</li>
</ul>
<h3>Education &amp; Training</h3>
<ul>
<li>Medical School: Shahid Beheshti University of Medical Sciences</li>
<li>Residency: Kingsbrook Jewish Medical Center</li>
<li>Fellowship: Hofstra-North Shore LIJ School of Medicine</li>
<li>Fellowship: Washington University in Saint Louis</li>
</ul>
<h3>Professional Memberships</h3>
<ul>
<li>American Association of Bronchology and Interventional Pulmonology (AABIP), Member</li>
<li>American College of Chest Physicians (ACCP), Member</li>
<li>American Thoracic Society (ATS), Member</li>
<li>International Association for the Study of Lung Cancer&nbsp;(IASLC),&nbsp;Member</li>
</ul>

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Clinical Focus

Dr. Sadoughi specializes in interventional pulmonology, a subspecialty of pulmonary and critical care medicine that uses endoscopy and other minimally invasive tools to diagnose and treat patients with benign and malignant chest diseases.

Elsevier Profile

Selected Publications

<ol>
<li>Bronchomediastinal Fistula From Erosion of Surgical Pledgets Into the Airway, Sadoughi A, Meyers B, Chenna P, Chest. 2015;148:838A. doi:10.1378/chest.2261266</li>
<li>Obstruction of the Trachea with Necrotic Tissue from a Pleomorphic Lung Carcinoma,&nbsp;Sadoughi A, Hyman K, Patel D, Chest. 2014;146:768A. doi:10.1378/chest.1991851.</li>
<li>Diagnosis and Safe Ablation of Endobronchial Hamartoma with Interventional Bronchoscopy,&nbsp;Sadoughi A, Folch E, Majid A. Am J Respir Crit Care Med 189;2014:A4447.</li>
<li>Macrophage migration inhibitory factor mediates hypoxia- induced pulmonary hypertension, Yinzhong Zhang, Arunabh Talwar, Donna Tsang, Annette Bruchfeld, Ali Sadoughi, Maowen Hu, Kennedy Omonuwa, Kai Fan Cheng, Yousef Al-Abed, and Edmund J. Miller, Molecular Medicine, Nov 2011, PMID: 22113497.</li>
<li>Impaired Heart Rate Recovery After Cardio Pulmonary Exercise Testing [CPET] In Patients with Pulmonary Arterial Hypertension, Arunabh Talwar MD, Ali Sadoughi&nbsp; MD,&nbsp; Purvesh&nbsp; Patel MD,&nbsp; Tara George, Donna Tsang, Nina Kohn MS; Chest. 2011;140(4_MeetingAbstracts):723A. doi:10.1378/chest.1119783</li>
<li>A 77-year-old woman with dyspnea and Reynaud phenomenon. Wang J, Sadoughi A, Dedopoulos S, Talwar A, Chest. 2011 Apr;139(4):958-6. PMID: 21467065</li>
<li>Intracranial Pressure Treatment Tailored to Transcranial Doppler-Derived Compliance and Perfusion. Kapinos G, Sadoughi A, Narayan R, oral presentation, November 2013 at the 15th International Conference on Intracranial Pressure and Brain Monitoring, Singapore.</li>
<li>Management of Increased Intracranial Pressure. Sadoughi A, Rybinnik I, Cohen R. The Open Critical Care Medicine Journal, 2013, 6, (Suppl 1: M4) 56-65.</li>
<li>Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Pulmonary Arterial Hypertension, Sadoughi A, Roberts K, Preston I, Lai GP, Mcollister D, Farber HW, Hill NS, Chest. 2013 Apr 4. PMID: 23558791.</li>
<li>Inflammatory Mechanisms in Pulmonary Hypertension, A Sadoughi, Y Zhang, EJ Miller, A Talwar; <em>CML (Current Medical Literature) &ndash; Pulmonary Hypertension </em>2010;1(4):93&ndash;106.</li>
<li>Computed Tomography Angiogram of the Chest as a Valuable Predicting Tool for Pulmonary Arterial Hypertension, A Sadoughi, N Patel, J Wang, N Kohn, R Shah, A Talwar; Chest. 2010;138(4_MeetingAbstracts):357A. doi:10.1378/chest.10559</li>
<li>Arterial Concentration of Macrophage Migration Inhibitory Factor (MIF) increases with exercise in patients with pulmonary Hypertension (PH), A Sadoughi, EJ Miller, A Talwar, presented at FOCIS 2011, Washington, DC.</li>
<li>Utility of Pulmonary Artery Diameter in Computed Tomography of Chest as a screening tool for Pulmonary Arterial Hypertension, A Sadoughi, T Chandak, N Kohn, R Shah, A Talwar, Presented in ATS Meeting, May 2010.</li>
<li>Relationship of Pulmonary Arterial Oxygen Saturation with Right Atrial Pressure in Pulmonary Hypertension, T Chandak, A Sadoughi, N Kohn, A Talwar, Presented in ATS Meeting, May 2010.</li>
<li>A case of Portopulmonary Hypertension, Sadoughi A, Mukherji R, Mehra S, Talwar A, The Journal of Respiratory Diseases, September, 2008.</li>
<li>Arteriotomy Closure Device Application Following Percutaneous Coronary Intervention May Prevent Bleeding Complication in Patients with Acute Myocardial Infarction, F. Ikeno, M. Ali Sadoughi, J. Lyons, F. Raissi, K. Pourdehmobed, V. Hashemi, S. Emami, H. Kaneda, A. C. Yeung, M. Rezaee, International J. of Cardiology, April 2007, 117(1), 131-132, PMID:16935367.</li>
<li>The Conversion in Application of Percutaneous Coronary Intervention Following the Introduction of Drug Eluting Stents, F. Ikeno, F. Raissi, M. Ali Sadoughi, J.K. Lyons, K. Pourdehmobed, V. Hashemi, S. Emami, H. Kanada, A.C. Yeung, M. Rezaee, International Journal of Cardiology, November 2006, 113(2), 279-280, PMID: 16318883.</li>
<li>Drug-eluting stents alter referral patterns for revascularization in patients with multivessel coronary artery disease, HMO Farouque, Fearon WF, Wu BM, Luna J, Shabari FR, Sadoughi MA, Lee DP, Yeung AC, Heart, Lung, Circulation 2005; 14 Suppl 1: S77, Australia</li>
<li>Changes in the Practice of Percutaneous Coronary Intervention Following the Introduction of Drug Eluting Stents, Raissi F., Sadoughi M.A., Hashemi V., Pourdehmobed K., Farouque O., Lyons J., Emami S., Ikeno F., Kaneda H., Yeung A.C., Rezaee M., TCT (Transcatheter Cardiovascular Therapeutics) meeting 2004, Washington DC, Poster Presentation, 09 / 2004.</li>
</ol>

EMR ID

78160

Biography

<p>Ali Sadoughi, MD, is Director, Interventional Pulmonology and Bronchoscopy and Associate Professor, Medicine at Montefiore Einstein. He specializes in interventional pulmonology, a subspecialty of pulmonary and critical care medicine that uses endoscopy and other minimally invasive tools to diagnose and treat patients with benign and malignant chest diseases.</p><p>After earning his Doctor of Medicine at Shahid Beheshti University of Medical Sciences in Tehran, Iran, Dr. Sadoughi completed an internal medicine residency at Kingsbrook Jewish Medical Center. Following this, he completed a pulmonary and critical care fellowship at Hofstra-North Shore LIJ School of Medicine in 2014 and an interventional pulmonary fellowship at Washington University in 2015.</p><p>Dr. Sadoughi's research interests are in developing and applying advanced technologies for early and minimally invasive diagnosis and treatment of pulmonary diseases. These include lung cancers, airway disorders, pulmonary hypertension, interstitial lung disease, respiratory failure and pleural diseases. His work has been published in journals including <em>Chest</em> and the <em>Journal of Molecular Medicine</em>, and he has made presentations at national and international medical meetings. One of his recent research studies focuses on the development of brachytherapy seeds (DaRT) using alpha radiation for the treatment of lung cancer, sponsored by Alpha Tau Ltd. In another study, he works with an international group of pulmonologists on the role of confocal laser endomicroscopy (CLE) in the diagnosis of different benign and malignant lung diseases. His work related to increased precision and accuracy of biopsy of peripheral lung nodules by intraprocedural 3D scanning in combination with ultrathin bronchoscopy has been published in the <em>Journal of Bronchology and Interventional Pulmonology</em>. Another area of Dr. Sadoughi&rsquo;s research involves the synergy of local therapies such as cryotherapy with immunotherapy in the treatment of lung cancer. He has presented this exciting topic at the American Association of Bronchology and Interventional Pulmonology (AABIP) Conference in 2022.</p><p>Dr. Sadoughi is board certified in interventional pulmonology, pulmonary disease, critical care medicine and internal medicine. He is a member of professional societies such as the American Association of Bronchology and Interventional Pulmonology, the World Association of Bronchology and Interventional Pulmonology, the American College of Chest Physicians, the American Thoracic Society and the International Association for the Study of Lung Cancer. He has contributed his research to the U.S. News, Politico New York and OncLive, and has been an editorial member and reviewer of multiple medical journals.</p>

Is Open Scheduling

On

Alejandra I. Sacasa

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/def64050-0f08-11ef-8dfd-d5d86707fe54.jpg

First Name

Alejandra

Last Name

Sacasa

NPI

1730542796

Faculty ID

17644

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Adult

Department

Gender

Female

Provider Type

Primary Care

Email

Phone

Titles

Locations

Education and Trainings

Research Profile

Clinical Profile

CHAM Provider

Off

Professional Title

Elsevier Profile

EMR ID

113616

Is Open Scheduling

Off

Tamar Rubinstein

https://documentapi-fargate-documentbucket-15qi4tpdvnhlz.s3.amazonaws.com/218/0e487770-0b89-11ef-9499-d9726cc0faa5.jpg

First Name

Tamar

Last Name

Rubinstein

NPI

1952544611

Faculty ID

13686

CMO Specialties

Clinical Terms

Employment Status

Full Time

Patient Type

Pediatric

Department

Gender

Female

Email

Phone

Titles

Locations

Education and Trainings

Professional Interests

<p>Tamar Rubinstein, MD, MS, is a Pediatric Rheumatologist at Children's Hospital at Montefiore and an Assistant Professor of Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is the treatment of children, adolescents and young adults with complex rheumatologic diseases, with a special interest in leading multidisciplinary care of patients with Systemic Lupus Erythematosus (SLE).</p>
<p>Dr. Rubinstein obtained her Medical Doctorate and Master of Science in Clinical Research Methods at Albert Einstein College of Medicine. After completing her residency at Johns Hopkins Hospital, Dr. Rubinstein went on to complete her fellowship training in Pediatric Rheumatology at Children's Hospital at Montefiore in 2016.</p>
<p>Dr. Rubinstein has authored numerous publications and continues to actively propose new lines of research with hopes to improve the mental health and SLE disease outcomes in youth. She is an active member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and a leader of the CARRA Mental Health Workgroup. Dr. Rubinstein is a recipient of the Lupus Foundation of America Career Development Award, the Rheumatology Research Foundation K-Bridge Award, and has received additional funding from CARRA and the Arthritis Foundation for her research. She is currently a lead investigator in the Einstein Pediatric Lupus Cohort.</p>

Research Areas

Research Profile

Clinical Profile

CHAM Provider

On

Professional Title

Clinical Focus

Dr. Rubenstein's clinical focus is the treatment of children, adolescents and young adults with complex rheumatologic diseases, with a special interest in leading multidisciplinary care of patients with Systemic Lupus Erythematosus (SLE).

Research Focus

Dr. Rubinstein has authored numerous publications and continues to actively propose new lines of research with hopes to improve the mental health and SLE disease outcomes in youth.&nbsp;

Elsevier Profile

Selected Publications

<p>Freilich B, Feirsen N, Welton E, Mowrey W, <strong>Rubinstein T</strong>. Validation of the Attention, Memory, and Frontal Abilities Screening Test (AMFAST). Assessment. 2019 Jan 9, doi: 10.1177/ 1073181118822734.</p>
<p>Smith EMD, Eleuteri A, Goilav B, Lewandowski L, Phuti A, <strong>Rubinstein T</strong>, Wahezi D, Jones CA, Marks SD, Corkhill R, Pilkington C, Tullus K, Putterman C, Scott C, Fisher AC, Beresford MW. A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. Clinical Immunology. 2019 Jan; 198:71-78.</p>
<p>Knight A, Vickery M, Faust L, Muscal E, Davis A, Harris J, Hersh A, Rodriguez M, Onel K,<strong> <strong>Rubinstein T</strong></strong>, Washington N, Weitzman ER, Conlon H, Woo JMP, Gerstbacher D, von Scheven E; CARRA Investigators. Gaps in mental health care for youth with rheumatologic conditions: a mixed methods study of perspectives from behavioral health providers [published online June 28, 2018]. Arthritis Care Res (Hoboken). doi: 10.1002/acr.23683</p>
<p><strong>Rubinstein T</strong>, Mowrey W, Ilowite N, Wahezi D; CARRA Investigators. Delays to care in pediatric lupus patients from the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis Care and Research. 2018; 70(3):420-427.&nbsp;</p>
<p><strong>Rubinstein T</strong>, Davis A, Rodriguez M, Knight A. Addressing Mental Health in Pediatric Rheumatology. Current Treatment Options in Rheumatology. 2018; 4(1):55-72.</p>
<p>Davis A, <strong>Rubinstein T</strong>, Rodriguez M, Knight A. Mental Health Care for Youth with Rheumatologic Diseases - Bridging the Gap. <em>Pediatric Rheumatology</em>. 2017 Dec;15(1):85.</p>
<p>Knight AM, Vickery ME, Muscal E, Davis AM, Harris JG, Soybilgic A, Onel KB, Schanberg LE, <strong>Rubinstein T</strong>, Gottlieb BS, Mandell DS, von Scheven E. Identifying Targets for Improving Mental Healthcare of Adolescents with Systemic Lupus Erythematosus: Perspectives from Pediatric Rheumatology Clinicians in the United States and Canada. Journal of Rheumatology. 2016 Jun;43(6):1136-45.</p>
<p><strong>Rubinstein T</strong>, Putterman C, Goilav B. Biomarkers for CNS involvement in pediatric lupus. <em>Biomarkers in Medicine</em>. 2015;9(6):545-58.</p>
<p>Goilav B, Putterman C, <strong>Rubinstein T</strong>. Biomarkers for kidney involvement in pediatric lupus. <em>Biomarkers in Medicine.</em> 2015;9(6):529-43.&nbsp;&nbsp;</p>
<p><strong><strong>Rubinstein T</strong></strong>,Pitashny M, Levine B, Schwartz N, Schwartzman J, Weinstein E, Pego-Reigosa JM, Lu TY, Isenberg D, Rahman A, Putterman C. Urinary neutrophil gelatinase-associated lipocalin as a novel biomarker for disease activity in lupus nephritis. Rheumatology. 2010 May;49(5):960-71.&nbsp;</p>
<p><strong>Rubinstein T</strong>, Pitashny M, Putterman C. The novel role of neutrophil gelatinase-B associated lipocalin (NGAL)/Lipocalin-2 as a biomarker for lupus nephritis. Autoimmunity Reviews. 2008 Jan;7(3):229-34.</p>

EMR ID

57123

Biography

<p>Tamar Rubinstein, MD, MS, is a Pediatric Rheumatologist at Children's Hospital at Montefiore and an Assistant Professor of Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is the treatment of children, adolescents and young adults with complex rheumatologic diseases, with a special interest in leading multidisciplinary care of patients with Systemic Lupus Erythematosus (SLE).</p><p>Upon graduating with a Bachelor of Science from Yale University, Dr. Rubinstein obtained her Medical Doctorate and Master of Science in Clinical Research Methods at Albert Einstein College of Medicine. After completing her residency at Johns Hopkins Hospital, Dr. Rubinstein then went on to complete her fellowship training in Pediatric Rheumatology at Children's Hospital at Montefiore in 2016</p><p>Dr. Rubinstein has authored numerous publications and continues to actively propose new lines of research with hopes to improve the mental health and SLE disease outcomes in youth. She is an active member of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) and a leader of the CARRA SLE Mental Health Workgroup. Dr. Rubinstein is a recipient of the Lupus Foundation of America Career Development Award and has received additional funding from CARRA for her research investigating mood disorder in pediatric lupus. She is currently a lead investigator in the Einstein Pediatric Lupus Cohort fostering collaborative studies in pediatric rheumatology.</p>

Is Open Scheduling

Off